GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » Net Issuance of Debt

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Net Issuance of Debt : ¥0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's net issuance of debt for the three months ended in Mar. 2025 was ¥0.0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.0 Mil.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Net Issuance of Debt Historical Data

The historical data trend for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Net Issuance of Debt Chart

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Traded in Other Exchanges
N/A
Address
No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines